 ROCHESTER, Mich., Feb. 08, 2021 GLOBE NEWSWIRE -- OptimizeRx Corporation Nasdaq: OPRX OptimizeRx, a leading provider of digital health solutions for life science companies, physicians and patients, today announced it has commenced an underwritten public offering of shares of its common stock. OptimizeRx is expected to grant the underwriters a 30-day option to purchase up to an additional 15 of the shares of common stock being offered at the public offering price, less underwriting discounts and commissions. All of the shares will be offered by OptimizeRx. 